Whistleblowers: Incentives, Disincentives, and Protection Strategies



A timely and much-needed resource guiding businesses in managing their whistleblower policies in light of the new Dodd-Frank Act provisions, this book shines a light on a topic that, until now, has been the pink elephant in the corporate boardroom. Critically examining current deterrents to whistleblowing, author Frank Lipman provides best practices for working with whistleblowers. 

Highlights of this book include: 

  • Case studies of GlaxoSmithKline, Pfizer and other high profile whistleblower incidences
  • Examines new Dodd-Frank incentives to whistleblowers
  • Recommends best practices for corporations in light of new whistleblowing incentives
  • Explores other federal and state statutory incentives to whistleblowing

Product Details

ISBN 978-1-118-09403-7
Hardcover, 272 PAGES

Table of Contents:

  • Chapter 1: The Dramatic Expansion of Whistleblower Awards under Dodd-Frank
  • Chapter 2: The Remarkable Story of Cheryl Eckard and the $96 Million Bounty under the False Claims Act
  • Chapter 3: The Pfizer Whistleblowers Who Collected Over $100 Million under the False Claims Act
  • Chapter 4: Disincentives to Internal Whistleblowers
  • Chapter 5: Women as Whistleblowers: Factors Motivating Public Whistleblowing
  • Chapter 6: Why Should Organizations Adopt a Robust Whistleblower System?
  • Chapter 7: Establishing a Robust Whistleblower System
  • Chapter 8: The False Claims Act: Qui Tam Cases
  • Chapter 9: IRS Whistleblowers
  • Chapter 10: Other Statutory Incentives and Protections for Whistleblowers
  • Chapter 11: A Step-by-Step Guide to SEC Whistleblowers Awards under Dodd-Frank